Sanrox 0.25 mg Combipack Injection 1's

Sanrox 0.25 mg Combipack Injection 1's belongs to the class of drugs called hormones used to treat female infertility in women. Infertility is unable to become pregnant after trying for a year. Female infertility may be caused due to different factors affecting ovulation (release of an egg from the ovary), fertilization (fusion of sperm and egg), and implantation (fertilized egg attaches to uterus lining).

If eggs are released too early during fertility treatment, they may not be suitable for fertilization. Sanrox 0.25 mg Combipack Injection 1's contains Cetrorelix, an anti-gonadotropin-releasing hormone that works by blocking a natural hormone in the body. Thereby, it inhibits premature ovulation (the release of eggs from the ovary too early).

Take Sanrox 0.25 mg Combipack Injection 1's as prescribed by your doctor. You are advised to take Sanrox 0.25 mg Combipack Injection 1's for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience itching, redness, or swelling at the site of injection, headache, or nausea. Most of these side effects of Sanrox 0.25 mg Combipack Injection 1's do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Sanrox 0.25 mg Combipack Injection 1's or any other medicines, please tell your doctor. Avoid taking Sanrox 0.25 mg Combipack Injection 1's if you are pregnant or breastfeeding, and consult a doctor before taking Sanrox 0.25 mg Combipack Injection 1's. If you experience lower stomach pain with nausea or vomiting, please consult a doctor immediately as these might be signs of the ovarian hyper-stimulation syndrome (OHSS).

Sanrox 0.25 mg Combipack Injection 1's used in the treatment of Female infertility. The detailed uses of Sanrox 0.25 mg Combipack Injection 1's are as follows:

• Controlled Ovarian Stimulation: Sanrox 0.25 mg Combipack Injection 1's prevents premature ovulation, allowing for better control and timing of fertility treatments.
• Inhibition of Premature LH Surge: Sanrox 0.25 mg Combipack Injection 1's works by blocking gonadotropin-releasing hormone (GnRH), delaying ovulation, and supporting effective fertility management.

• Follow your doctor's instructions on the dosage and timing of this medication to ensure safety.
• Check the label for directions and use it as advised by the doctor.
• Sanrox 0.25 mg Combipack Injection 1's should be injected into the lower abdomen, at least one inch away from the belly button.
• Choose a different injection site each day to minimize irritation.

Sanrox 0.25 mg Combipack Injection 1's contains Cetrorelix, a hormone that blocks a natural hormone in the body. Thereby, it inhibits premature ovulation (release of eggs from the ovary too early). If eggs are released too early during fertility treatment, they may not be suitable for fertilization.

If you are allergic to Sanrox 0.25 mg Combipack Injection 1's or any other medicines, please tell your doctor. If you have any kidney or liver problems, inform your doctor before taking Sanrox 0.25 mg Combipack Injection 1's. Avoid taking Sanrox 0.25 mg Combipack Injection 1's if you are pregnant or breastfeeding, and consult a doctor before taking Sanrox 0.25 mg Combipack Injection 1's. You are recommended to remove Sanrox 0.25 mg Combipack Injection 1's from the refrigerator 30 minutes before using it. Wash your hands and inject Sanrox 0.25 mg Combipack Injection 1's under the skin of the belly as instructed by your doctor. If you experience lower stomach pain with nausea or vomiting, please consult a doctor immediately as these might be signs of ovarian hyper-stimulation syndrome (OHSS).